Opioid Prescribing and Substance Use Disorder in Pain Management
Course Overview
This CME course focuses on the critical aspects of opioid prescribing and the management of substance use disorder in pain management. Participants will explore evidence-based guidelines for prescribing opioids safely, recognizing the risks of addiction, and alternative pain management strategies. The course emphasizes a multidisciplinary approach, integrating clinical education on screening, intervention, and support for patients with substance use disorders.
Course Objectives
Apply evidence-based criteria for initiating opioid therapy.
Evaluate risk factors for opioid misuse, SUD, and overdose.
Implement best practices for monitoring chronic opioid therapy.
Use multimodal, non-opioid, and interventional alternatives appropriately.
Meet state and federal regulatory and documentation requirements.
Target Audience
Physicians: Especially those in primary care, pain management, and addiction medicine.
Nurse Practitioners: Involved in pain management and patient care.
Physician Assistants: Working in settings where opioid prescribing is common.
Nurses: Providing care to patients with acute or chronic pain.
Credit Information
Credit Type
* AMA PRA Category 1™
Number of Credits
2
* AMA PRA Category 1 ™ credits are used by physicians and other groups like PAs and certain nurses. Category 1 credits are accepted by the ARDMS, CCI, ACCME, and Sonography Canada.
Faculty
Jeffrey Kesten, MD
Disclosure
None of the speakers, planners, nor reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients. All of the relevant financial relationships listed have been mitigated. Remaining persons in control of content have no financial relationships.
Estimated Time for Completion
2 hours
Date of Release
December 20th, 2025
Date of Most Recent Review
December 20th, 2025
Expiration Date
December 20th, 2028
